Evidence for a new G protein-coupled cannabinoid receptor in mouse brain

Area of Science:

• Neuroscience
• Pharmacology
• Molecular Biology

Background:

• The endocannabinoid system plays a crucial role in regulating various physiological processes.
• The CB1 receptor is the primary cannabinoid receptor in the central nervous system, but its complete function is not fully understood.

Purpose of the Study:

• To investigate the hypothesis that an undiscovered cannabinoid receptor exists in the brain.
• To characterize the binding and signaling properties of potential novel cannabinoid receptors.

Main Methods:

• Utilized [(35)S]GTP gamma S binding assays in brain membranes from CB(1)(+/+) and CB(1)(-/-) mice.
• Tested the effects of various cannabinoid receptor agonists and antagonists, including anandamide, WIN55212-2, and SR141716A.
• Performed radioligand binding studies using [(3)H]WIN55212-2 and [(3)H]CP55940.
• Assessed cannabinoid activity in different central nervous system (CNS) regions.

Main Results:

• Anandamide and WIN55212-2 stimulated [(35)S]GTP gamma S binding in CB(1)(-/-) membranes, unlike other known CB1 receptor agonists.
• SR141716A showed reduced affinity for inhibiting anandamide and WIN55212-2 activity in CB(1)(-/-) membranes.
• Cannabinoid activity was detected in various CNS regions of CB(1)(-/-) mice, including brain stem, cortex, and hippocampus.
• Distinct binding patterns were observed for [(3)H]WIN55212-2 and [(3)H]CP55940 in CB(1)(-/-) membranes.

Conclusions:

• The findings strongly suggest the existence of a novel cannabinoid receptor subtype in the brain.
• This putative receptor is activated by anandamide and WIN55212-2 and has a distinct distribution within the CNS.
• Further research is warranted to identify and characterize this new receptor and its pharmacological significance.